The soluble metalloendoprotease required in myoblast fusion remains intracellular

Area of Science:

• Muscle regeneration and cell biology
• Enzymology and protease function
• Cellular signaling pathways

Background:

• Myoblast fusion is essential for skeletal muscle development and repair.
• A soluble metalloendoprotease has been identified as a key factor in this process.
• The precise localization of this protease during fusion has remained undetermined.

Purpose of the Study:

• To ascertain whether the essential soluble metalloendoprotease is released extracellularly or retained intracellularly by fusing myoblasts.
• To investigate the role of protease localization in myoblast fusion.

Main Methods:

• Utilizing membrane-permeant (1,10-phenanthroline) and membrane-impermeant (bathophenanthroline disulfonic acid) metalloendoprotease inhibitors.
• Assessing protease activity in homogenized myoblasts and cell culture media.
• Quantifying the impact of inhibitors on both enzymatic activity and myoblast fusion.

Main Results:

• Both inhibitors demonstrated equal potency in suppressing soluble metalloendoprotease activity in homogenized myoblasts.
• The membrane-permeant inhibitor (1,10-phenanthroline) effectively blocked myoblast fusion.
• The membrane-impermeant inhibitor (bathophenanthroline disulfonic acid) did not affect fusion, and activity was detected intracellularly, not in the media.

Conclusions:

• The soluble metalloendoprotease required for myoblast fusion is retained within the cell.
• Intracellular localization of the protease is critical for its function in myoblast fusion.
• These findings clarify the cellular compartment involved in protease-mediated myogenesis.